Cargando…

DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1

Pathological cardiac hypertrophy involves multiple regulators and several signal transduction pathways. Currently, the mechanisms of it are not well understood. Differentially expressed in FDCP 6 homolog (DEF6) was reported to participate in immunity, bone remodeling, and cancers. The effects of DEF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yan, Xu, Changlu, Jiang, Zhongxiu, Jiang, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390462/ https://www.ncbi.nlm.nih.gov/pubmed/37524688 http://dx.doi.org/10.1038/s41419-023-05948-0

Ejemplares similares

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016)

Tripartite motif 32 prevents pathological cardiac hypertrophy
por: Chen, Lijuan, et al.
Publicado: (2016)

Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy
por: Yang, Jing-jing, et al.
Publicado: (2021)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

The Role of CD147 in Pathological Cardiac Hypertrophy Is Regulated by Glycosylation
por: Zhong, Fang-yuan, et al.
Publicado: (2022)

DEF6 expression in ovarian carcinoma correlates with poor patient survival
por: Liew, Phui-Ly, et al.
Publicado: (2016)

Diccionario de especialidades farmacéuticas, DEF.
Publicado: (2016)

Diccionario de especialidades farmacéuticas, DEF.
Publicado: (2014)

Diccionario de especialidades farmacéuticas, DEF.
Publicado: (2013)

Sirt1: Def-eating senescence?
por: Fusco, Salvatore, et al.
Publicado: (2012)

4H-Cyclopenta[def]phenanthren-4-one
por: Jiang, Wen-Sheng, et al.
Publicado: (2009)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Deubiquitinase Ubiquitin‐Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy
por: Zhang, Dian‐Hong, et al.
Publicado: (2020)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017)

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019)

CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway
por: Li, Yue, et al.
Publicado: (2023)

Phosphorylation of Def Regulates Nucleolar p53 Turnover and Cell Cycle Progression through Def Recruitment of Calpain3
por: Guan, Yihong, et al.
Publicado: (2016)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020)

Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway
por: Li, Chen, et al.
Publicado: (2016)

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
por: Zhuang, Lingfang, et al.
Publicado: (2021)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022)

Inhibition of GTPase Rac1 expression by vitamin D mitigates pressure overload-induced cardiac hypertrophy
por: Moradi, Ali, et al.
Publicado: (2021)

Def6 regulates endogenous type-I interferon responses in osteoblasts and suppresses osteogenesis
por: Deng, Zhonghao, et al.
Publicado: (2020)

The intergenic region of the maize defensin-like protein genes Def1 and Def2 functions as an embryo-specific asymmetric bidirectional promoter
por: Liu, Xiaoqing, et al.
Publicado: (2016)

Structure-Activity Determinants in Antifungal Plant Defensins MsDef1 and MtDef4 with Different Modes of Action against Fusarium graminearum
por: Sagaram, Uma Shankar, et al.
Publicado: (2011)

Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
por: Chen, Youming, et al.
Publicado: (2020)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

CIB1 is a Regulator of Pathological Cardiac Hypertrophy
por: Heineke, Joerg, et al.
Publicado: (2010)

Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy
por: Naskar, Shaon, et al.
Publicado: (2014)

Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2020)

Development of the dog executive function scale (DEFS) for adult dogs
por: Foraita, Maike, et al.
Publicado: (2022)

SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU)
por: Vistica, Barbara P., et al.
Publicado: (2012)

Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis
por: Serwas, Nina K., et al.
Publicado: (2019)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis
por: Sukumaran, Abitha, et al.
Publicado: (2017)

Caspase Cleavage of Gelsolin Is an Inductive Cue for Pathologic Cardiac Hypertrophy
por: Putinski, Charis, et al.
Publicado: (2018)

Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
por: Fernandez-Caggiano, Mariana, et al.
Publicado: (2020)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a04kee7ifo4amekh6c0d3i9o3a